Home/Filings/4/0000899243-20-000275
4//SEC Filing

Brown William Michael 4

Accession 0000899243-20-000275

CIK 0001326190other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:00 PM ET

Size

5.8 KB

Accession

0000899243-20-000275

Insider Transaction Report

Form 4
Period: 2020-01-02
Brown William Michael
Acting Chief Financial Officer
Transactions
  • Award

    Stock Options (option to buy)

    2020-01-02+61,40061,400 total
    Exercise: $1.92Exp: 2030-01-02Common Stock, par value $0.0001 (61,400 underlying)
Footnotes (1)
  • [F1]Twenty-five percent of the shares underlying the option become vested and exercisable on January 2, 2021 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 2, 2021, subject to the reporting person's continued service through the applicable vesting date.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001742241

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:00 PM ET
Size
5.8 KB